According to Markntel Advisors Report, Radiopharmaceuticals Market is expected to grow at a significant growth rate, and the analysis period is 2025-2030, considering the base year as 2024.Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.
Radiopharmaceuticals are specialized medications comprising a carrier molecule, often a pharmaceutical agent or biomolecule, combined with a radioactive isotope. These compounds emit radiation that can be detected by imaging devices for diagnostic purposes or deliver targeted radiation therapy to treat diseases, such as cancer.
Radiopharmaceuticals Market Research Report & Summary:
The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30.
Time Period Captured in the Report:
· Historical Years: 2020-2023
· Base Years: 2024
· Forecast Years: 2025-2030
Who are the Key Players Operating in the Radiopharmaceuticals Market?
The top companies of the Solar Water Desalination Plant Market ruling the industry are:
Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report- https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")
What is Included in Radiopharmaceuticals Market Segmentation?
The Solar Water Desalination Plant Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:
- By Radioisotope
- Technetium 99- Market Size & Forecast 2020-2030, USD Million
- Fluorine 18- Market Size & Forecast 2020-2030, USD Million
- Iodine 131- Market Size & Forecast 2020-2030, USD Million
- Gallium 68- Market Size & Forecast 2020-2030, USD Million
- Iodine 123- Market Size & Forecast 2020-2030, USD Million
- Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
- By Indication
- Oncology- Market Size & Forecast 2020-2030, USD Million
- Cardiology- Market Size & Forecast 2020-2030, USD Million
- Gastroenterology- Market Size & Forecast 2020-2030, USD Million
- Nephrology- Market Size & Forecast 2020-2030, USD Million
- Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
- By Type
- Diagnostic- Market Size & Forecast 2020-2030, USD Million
- Therapeutic- Market Size & Forecast 2020-2030, USD Million
- By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
- Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Explore the Complete Radiopharmaceuticals Market Analysis Report – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
Radiopharmaceuticals Market Driver:
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals
Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/radiopharmaceuticals-market.html
Why Markntel Advisor Report?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Further Queries:
Contact Us
MarkNtel Advisors
Email at -sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
